This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Delcath Systems, Inc. operates as a specialty pharmaceutical and medical device company focusing on cancers of the liver.View DCTH key stats
Delcath Systems Inc - DCTH - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Delcath Systems Inc as a
Sell with a ratings score of D-.
Report Snippet: We rate DELCATH SYSTEMS INC (DCTH) a SELL. This is driven by several weaknesses, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. The company's weaknesses can be seen in multiple areas, such as its disappointing return on equity and generally disappointing historical performance in the stock itself.